NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

醫藥品中間體的全球市場:未來預測 (2028年),新型冠狀病毒感染疾病 (COVID-19)的影響,各類型·各用途·各流通管道·各地區的分析

Pharmaceutical Intermediate Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type, Applications, and Distribution Channel and Geography

出版商 The Insight Partners 商品編碼 1004671
出版日期 內容資訊 英文 159 Pages
訂單完成後即時交付
價格
醫藥品中間體的全球市場:未來預測 (2028年),新型冠狀病毒感染疾病 (COVID-19)的影響,各類型·各用途·各流通管道·各地區的分析 Pharmaceutical Intermediate Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type, Applications, and Distribution Channel and Geography
出版日期: 2021年04月23日內容資訊: 英文 159 Pages
簡介

全球醫藥品中間體的市場規模預測將從2020年273億5670萬美元,在2028年之前達到372億9033萬美元。2021年到2028年的年複合成長率預測將為4.2%。

本報告提供全球醫藥品中間體的市場相關分析,彙整市場基本結構和背景情況 (主要促進·阻礙因素等),市場規模趨勢預測,各類型·各用途·各流通管道·各地區的詳細趨勢,主要企業的簡介與策略展開情形,近來新型冠狀病毒感染疾病 (COVID-19) 帶來的影響等資訊,為您概述為以下內容。

目錄

第1章 簡介

第2章 醫藥品中間體市場:分析概要

第3章 分析方法

第4章 醫藥品中間體市場:市場環境

  • 概要
  • PEST分析
  • 專家的見解

第5章 醫藥品中間體市場:主要的市場動態

  • 推動市場要素
  • 阻礙市場要素
  • 市場機會
  • 今後趨勢
  • 影響度分析

第6章 醫藥品中間體市場:全球市場分析

  • 市場收益額的預測與分析
  • 市場規模的預測與分析:各地區
  • 主要企業的市場定位

第7章 醫藥品中間體市場:不同種類的分析

  • 概要
  • 醫藥品中間體市場:各類型 (2020年/2028年)
  • GMP (合理製造標準) 依據
  • GMP非依據

第8章 醫藥品中間體市場:各用途分析

  • 概要
  • 醫藥品中間體市場:各用途 (2020年/2028年)
  • 抗生素
  • 解熱止痛藥
  • 維他命
  • 其他

第9章 醫藥品中間體市場:各流通管道

  • 概要
  • 醫藥品中間體市場:各流通管道 (2020年/2028年)
  • 經銷商
  • 直銷

第10章 醫藥品中間體市場:各地區的分析

  • 北美:醫藥品中間體市場,到市場收益額與其預測 (2028年)
  • 歐洲:醫藥品中間體市場,到市場收益額與其預測 (2028年)
  • 亞太地區:醫藥品中間體市場,到市場收益額與其預測 (2028年)
  • 中東·非洲:醫藥品中間體市場,到市場收益額與其預測 (2028年)
  • 中南美:醫藥品中間體市場,到市場收益額與其預測 (2028年)

第11章 全球醫藥品中間體市場:新型冠狀病毒感染疾病 (COVID-19) 感染擴大的影響

  • 北美:COVID-19感染擴大的影響度評估
  • 歐洲:COVID-19感染擴大的影響度評估
  • 亞太地區:COVID-19感染擴大的影響度評估
  • 中東·非洲:COVID-19感染擴大的影響度評估
  • 中南美:COVID-19感染擴大的影響度評估

第12章 醫藥品中間體市場:產業形勢

  • 概要
  • 各企業製定的成長策略
  • 有機的發展
  • 無機的發展

第13章 企業簡介

  • Pfizer Inc.
  • Sanofi
  • BASF SE
  • Lianhe Chemical Technology Co., Ltd.
  • Dishman Carbogen Amcis Ltd
  • Codexis
  • Midas Pharma GmbH
  • chiracon GmbH
  • Dextra Laboratories Limited
  • Vertellus Holdings LLC

第14章 附錄

目錄
Product Code: TIPRE00005559

The pharmaceutical intermediate market was valued at US$ 27,356.70 million in 2020 and is projected to reach US$ 37,290.33 million by 2028; it is expected to grow at a CAGR of 4.2% from 2021 to 2028.

The rising prevalence of chronic diseases and infectious diseases, and escalating investment by pharmaceutical companies in R&D activities drive the growth of the pharmaceutical intermediate market. However, the high cost of drug manufacturing hinders the market growth.

Pharmaceutical intermediates are the building blocks of active pharmaceutical ingredients (APIs). These are raw materials that undergo molecular change or processing during bulk drug production. Thus, the requirement of pharmaceutical intermediates increases with the rise in demand for drugs to treat chronic diseases. As per the Centers for Disease Control and Prevention (CDC), 6 in 10 adults in the US suffer from at least one chronic disease such as cancer, heart disease, lung disease, stroke, neurological disease, diabetes, and kidney diseases. Moreover, 4 in 10 adults in the country have two or more chronic diseases. Additionally, according to the press release by the European Chronic Disease Alliance (ECDA), in 2014, 9 out of 10 people in Europe die due to chronic diseases. Thus, 70-80% of the total healthcare costs are spent on the management of chronic diseases.

The surging prevalence of infectious diseases, especially in Southeast Asia, is also likely to propel the demand for APIs in the coming years, eventually driving the growth of the pharmaceutical intermediate market. For instance, as per the Revised National Tuberculosis Control Programme Report, around 4.4 lakh patients died due to tuberculosis in India in 2018, that is 29% of the total 1.5 million deaths caused by the disease across the world. Thus, such high prevalence of chronic diseases and infectious diseases is bolstering the demand for drugs, eventually highlighting the need of pharmaceutical intermediates.

Based on type, the pharmaceutical intermediate market is bifurcated into GMP and non GMP counters. In 2020, GMP accounted for a larger share in the market owing to increase in the adoption of good manufacturing practices (GMP) by pharmaceutical companies. These regulations are designed to reduce the risks involved in the production of pharmaceuticals that cannot be eliminated through testing the finished product.

In terms of application, the pharmaceutical intermediate market is segmented into antibiotics, antipyretic analgesics, vitamins, and others. The antibiotics segment held the largest share of the market in 2020, whereas the vitamins segment is estimated to register the highest CAGR in the market during the forecast period.

World Health Organization (WHO), European Chronic Disease Alliance (ECDA), US Food and Drug Administration (FDA), Pharmaceutical Research and Manufacturers Association (PhRMA), US Census Bureau, the Germany Trade & Invest (GTAI), European Medicine Agency (EMA), and Institute for Integrated Economic Research Australia are among the major secondary sources referred to while preparing the report on the pharmaceutical intermediate market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the pharmaceutical intermediate market.

Highlights key business priorities in order to assist companies to realign their business strategies.

The key findings and recommendations highlight crucial progressive industry trends in the global pharmaceutical intermediate market, thereby allowing players across the value chain to develop effective long-term strategies.

Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Global Pharmaceutical Intermediates Market - By Type
    • 1.3.2 Global Pharmaceutical Intermediates Market - By Application
    • 1.3.3 Global Pharmaceutical Intermediates Market - By Distribution Channel
    • 1.3.4 Global Pharmaceutical Intermediates Market- By Geography

2. Pharmaceutical Intermediates Market- Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Pharmaceutical Intermediates Market- Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America PEST Analysis
    • 4.2.2 Europe PEST Analysis
    • 4.2.3 APAC PEST Analysis
    • 4.2.4 MEA PEST Analysis
    • 4.2.5 SCAM PEST Analysis
  • 4.3 Expert Opinion

5. Pharmaceutical Intermediates Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Rising Prevalence of Chronic Diseases and Infectious Diseases
    • 5.1.2 Escalating R&D Investments by Pharmaceutical Companies
  • 5.2 Market Restraints
    • 5.2.1 High Cost of Manufacturing
  • 5.3 Market Opportunities
    • 5.3.1 Emerging Markets
  • 5.4 Future Trends
    • 5.4.1 Increasing Adoption of AI-based Tools for Drug Discovery
  • 5.5 Impact Analysis

6. Pharmaceutical Intermediates Market- Global Analysis

  • 6.1 Global Pharmaceutical Intermediates Market Revenue Forecast and Analysis
  • 6.2 Global Pharmaceutical Intermediates Market, By Geography - Forecast and Analysis
  • 6.3 Market Positioning of Key Players

7. Pharmaceutical Intermediates Market Analysis - By Type

  • 7.1 Overview
  • 7.2 Pharmaceutical Intermediates Market Revenue Share, by Type (2020 and 2028)
  • 7.3 GMP
    • 7.3.1 Overview
    • 7.3.2 GMP: Pharmaceutical Intermediates Market- Revenue and Forecast to 2028 (US$ Million)
  • 7.4 Non GMP
    • 7.4.1 Overview
    • 7.4.2 Non GMP: Pharmaceutical Intermediates Market- Revenue and Forecast to 2028 (US$ Million)

8. Pharmaceutical Intermediates Market Analysis - By Application

  • 8.1 Overview
  • 8.2 Pharmaceutical Intermediates Market Revenue Share, by Application (2020 and 2028)
  • 8.3 Antibiotics
    • 8.3.1 Overview
    • 8.3.2 Antibiotics: Pharmaceutical Intermediates Market- Revenue and Forecast to 2028 (US$ Million)
  • 8.4 Antipyretic Analgesics
    • 8.4.1 Overview
    • 8.4.2 Antipyretic Analgesics: Pharmaceutical Intermediates Market- Revenue and Forecast to 2028 (US$ Million)
  • 8.5 Vitamins
    • 8.5.1 Overview
    • 8.5.2 Vitamins: Pharmaceutical Intermediates Market- Revenue and Forecast to 2028 (US$ Million)
  • 8.6 Other
    • 8.6.1 Overview
    • 8.6.2 Other: Pharmaceutical Intermediates Market- Revenue and Forecast to 2028 (US$ Million)

9. Pharmaceutical Intermediates Market- By Distribution Channel

  • 9.1 Overview
  • 9.2 Pharmaceutical Intermediates Market, by Distribution Channel, 2020 and 2028 (%)
  • 9.3 Distributor
    • 9.3.1 Overview
    • 9.3.2 Distributor: Pharmaceutical Intermediates Market- Revenue and Forecast to 2028 (US$ Million)
  • 9.4 Direct Sales
    • 9.4.1 Overview
    • 9.4.2 Direct Sales: Pharmaceutical Intermediates Market- Revenue and Forecast to 2028 (US$ Million)

10. Pharmaceutical Intermediates Market - Geographical Analysis

  • 10.1 North America: Pharmaceutical Intermediates Market Revenue and Forecast to 2028
    • 10.1.1 Overview
    • 10.1.2 North America: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
    • 10.1.3 North America: Pharmaceutical Intermediates Market, by Type, 2019-2028 (USD Million)
    • 10.1.4 North America: Pharmaceutical Intermediates Market, by Application, 2019-2028 (USD Million)
    • 10.1.5 North America: Pharmaceutical Intermediates Market, by Distribution Channel, 2019-2028 (USD Million)
    • 10.1.6 North America: Pharmaceutical Intermediates Market, by Country, 2020 & 2028 (%)
    • 10.1.7 US: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
      • 10.1.7.1 US: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
      • 10.1.7.2 US: Pharmaceutical Intermediates Market, by Type, 2019-2028 (USD Million)
      • 10.1.7.3 US: Pharmaceutical Intermediates Market, by Application, 2019-2028 (USD Million)
      • 10.1.7.4 US: Pharmaceutical Intermediates Market, by Distribution Channel, 2019-2028 (USD Million)
    • 10.1.8 Canada: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
      • 10.1.8.1 Canada: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
      • 10.1.8.2 Canada: Pharmaceutical Intermediates Market, by Type, 2019-2028 (USD Million)
      • 10.1.8.3 Canada: Pharmaceutical Intermediates Market, by Application, 2019-2028 (USD Million)
      • 10.1.8.4 Canada: Pharmaceutical Intermediates Market, by Distribution Channel, 2019-2028 (USD Million)
    • 10.1.9 Mexico: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
      • 10.1.9.1 Mexico: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
      • 10.1.9.2 Mexico: Pharmaceutical Intermediates Market, by Type, 2019-2028 (USD Million)
      • 10.1.9.3 Mexico: Pharmaceutical Intermediates Market, by Application, 2019-2028 (USD Million)
      • 10.1.9.4 Mexico: Pharmaceutical Intermediates Market, by Distribution Channel, 2019-2028 (USD Million)
  • 10.2 Europe: Pharmaceutical Intermediates Market Revenue and Forecast to 2028
    • 10.2.1 Overview
    • 10.2.2 Europe: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
    • 10.2.3 Europe: Pharmaceutical Intermediates Market, by Type, 2019-2028 (USD Million)
    • 10.2.4 Europe: Pharmaceutical Intermediates Market, by Application, 2019-2028 (USD Million)
    • 10.2.5 Europe: Pharmaceutical Intermediates Market, by Distribution Channel, 2019-2028 (USD Million)
    • 10.2.6 Europe: Pharmaceutical Intermediates Market, by Country, 2020 & 2028 (%)
    • 10.2.7 Germany: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
      • 10.2.7.1 Germany: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
      • 10.2.7.2 Germany: Pharmaceutical Intermediates Market, by Type, 2019-2028 (USD Million)
      • 10.2.7.3 Germany: Pharmaceutical Intermediates Market, by Application, 2019-2028 (USD Million)
      • 10.2.7.4 Germany: Pharmaceutical Intermediates Market, by Distribution Channel, 2019-2028 (USD Million)
    • 10.2.8 UK: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
      • 10.2.8.1 UK: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
      • 10.2.8.2 UK: Pharmaceutical Intermediates Market, by Type, 2019-2028 (USD Million)
      • 10.2.8.3 UK: Pharmaceutical Intermediates Market, by Application, 2019-2028 (USD Million)
      • 10.2.8.4 UK: Pharmaceutical Intermediates Market, by Distribution Channel, 2019-2028 (USD Million)
    • 10.2.9 France: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
      • 10.2.9.1 France: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
      • 10.2.9.2 France: Pharmaceutical Intermediates Market, by Type, 2019-2028 (USD Million)
      • 10.2.9.3 France: Pharmaceutical Intermediates Market, by Application, 2019-2028 (USD Million)
      • 10.2.9.4 France: Pharmaceutical Intermediates Market, by Distribution Channel, 2019-2028 (USD Million)
    • 10.2.10 Spain: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
      • 10.2.10.1 Spain: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
      • 10.2.10.2 Spain: Pharmaceutical Intermediates Market, by Type, 2019-2028 (USD Million)
      • 10.2.10.3 Spain: Pharmaceutical Intermediates Market, by Application, 2019-2028 (USD Million)
      • 10.2.10.4 Spain: Pharmaceutical Intermediates Market, by Distribution Channel, 2019-2028 (USD Million)
    • 10.2.11 Italy: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
      • 10.2.11.1 Italy: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
      • 10.2.11.2 Italy: Pharmaceutical Intermediates Market, by Type, 2019-2028 (USD Million)
      • 10.2.11.3 Italy: Pharmaceutical Intermediates Market, by Application, 2019-2028 (USD Million)
      • 10.2.11.4 Italy: Pharmaceutical Intermediates Market, by Distribution Channel, 2019-2028 (USD Million)
    • 10.2.12 Rest of Europe: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
      • 10.2.12.1 Rest of Europe: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
      • 10.2.12.2 Rest of Europe: Pharmaceutical Intermediates Market, by Type, 2019-2028 (USD Million)
      • 10.2.12.3 Rest of Europe: Pharmaceutical Intermediates Market, by Application, 2019-2028 (USD Million)
      • 10.2.12.4 Rest of Europe: Pharmaceutical Intermediates Market, by Distribution Channel, 2019-2028 (USD Million)
  • 10.3 Asia Pacific: Pharmaceutical Intermediates Market Revenue and Forecast to 2028
    • 10.3.1 Overview
    • 10.3.2 Asia Pacific: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
    • 10.3.3 Asia Pacific: Pharmaceutical Intermediates Market, by Type, 2019-2028 (USD Million)
    • 10.3.4 Asia Pacific: Pharmaceutical Intermediates Market, by Application, 2019-2028 (USD Million)
    • 10.3.5 Asia Pacific: Pharmaceutical Intermediates Market, by Distribution Channel, 2019-2028 (USD Million)
    • 10.3.6 Asia Pacific: Pharmaceutical Intermediates Market, by Country, 2020 & 2028 (%)
    • 10.3.7 China: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
      • 10.3.7.1 China: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
      • 10.3.7.2 China: Pharmaceutical Intermediates Market, by Type, 2019-2028 (USD Million)
      • 10.3.7.3 China: Pharmaceutical Intermediates Market, by Application, 2019-2028 (USD Million)
      • 10.3.7.4 China: Pharmaceutical Intermediates Market, by Distribution Channel, 2019-2028 (USD Million)
    • 10.3.8 Japan: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
      • 10.3.8.1 Japan: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
      • 10.3.8.2 Japan: Pharmaceutical Intermediates Market, by Type, 2019-2028 (USD Million)
      • 10.3.8.3 Japan: Pharmaceutical Intermediates Market, by Application, 2019-2028 (USD Million)
      • 10.3.8.4 Japan: Pharmaceutical Intermediates Market, by Distribution Channel, 2019-2028 (USD Million)
    • 10.3.9 India: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
      • 10.3.9.1 India: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
      • 10.3.9.2 India: Pharmaceutical Intermediates Market, by Type, 2019-2028 (USD Million)
      • 10.3.9.3 India: Pharmaceutical Intermediates Market, by Application, 2019-2028 (USD Million)
      • 10.3.9.4 India: Pharmaceutical Intermediates Market, by Distribution Channel, 2019-2028 (USD Million)
    • 10.3.10 Australia: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
      • 10.3.10.1 Australia: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
      • 10.3.10.2 Australia: Pharmaceutical Intermediates Market, by Type, 2019-2028 (USD Million)
      • 10.3.10.3 Australia: Pharmaceutical Intermediates Market, by Application, 2019-2028 (USD Million)
      • 10.3.10.4 Australia: Pharmaceutical Intermediates Market, by Distribution Channel, 2019-2028 (USD Million)
    • 10.3.11 South Korea: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
      • 10.3.11.1 South Korea: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
      • 10.3.11.2 South Korea: Pharmaceutical Intermediates Market, by Type, 2019-2028 (USD Million)
      • 10.3.11.3 South Korea: Pharmaceutical Intermediates Market, by Application, 2019-2028 (USD Million)
      • 10.3.11.4 South Korea: Pharmaceutical Intermediates Market, by Distribution Channel, 2019-2028 (USD Million)
    • 10.3.12 Rest of Asia Pacific: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
      • 10.3.12.1 Rest of Asia Pacific: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
      • 10.3.12.2 Rest of Asia Pacific: Pharmaceutical Intermediates Market, by Type, 2019-2028 (USD Million)
      • 10.3.12.3 Rest of Asia Pacific: Pharmaceutical Intermediates Market, by Application, 2019-2028 (USD Million)
      • 10.3.12.4 Rest of Asia Pacific: Pharmaceutical Intermediates Market, by Distribution Channel, 2019-2028 (USD Million)
  • 10.4 Middle East & Africa: Pharmaceutical Intermediates Market Revenue and Forecast to 2028
    • 10.4.1 Overview
    • 10.4.2 Middle East and Africa: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
    • 10.4.3 Middle East and Africa: Pharmaceutical Intermediates Market, by Type, 2019-2028 (USD Million)
    • 10.4.4 Middle East and Africa: Pharmaceutical Intermediates Market, by Application, 2019-2028 (USD Million)
    • 10.4.5 Middle East and Africa: Pharmaceutical Intermediates Market, by Distribution Channel, 2019-2028 (USD Million)
    • 10.4.6 Middle East and Africa: Pharmaceutical Intermediates Market, by Country, 2020 & 2028 (%)
    • 10.4.7 Saudi Arabia: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
      • 10.4.7.1 Saudi Arabia: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
      • 10.4.7.2 Saudi Arabia: Pharmaceutical Intermediates Market, by Type, 2019-2028 (USD Million)
      • 10.4.7.3 Saudi Arabia: Pharmaceutical Intermediates Market, by Application, 2019-2028 (USD Million)
      • 10.4.7.4 Saudi Arabia: Pharmaceutical Intermediates Market, by Distribution Channel, 2019-2028 (USD Million)
    • 10.4.8 UAE: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
      • 10.4.8.1 UAE: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
      • 10.4.8.2 UAE: Pharmaceutical Intermediates Market, by Type, 2019-2028 (USD Million)
      • 10.4.8.3 UAE: Pharmaceutical Intermediates Market, by Application, 2019-2028 (USD Million)
      • 10.4.8.4 UAE: Pharmaceutical Intermediates Market, by Distribution Channel, 2019-2028 (USD Million)
    • 10.4.9 South Africa: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
      • 10.4.9.1 South Africa: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
      • 10.4.9.2 South Africa: Pharmaceutical Intermediates Market, by Type, 2019-2028 (USD Million)
      • 10.4.9.3 South Africa: Pharmaceutical Intermediates Market, by Application, 2019-2028 (USD Million)
      • 10.4.9.4 South Africa: Pharmaceutical Intermediates Market, by Distribution Channel, 2019-2028 (USD Million)
    • 10.4.10 Rest of Middle East and Africa: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
      • 10.4.10.1 Rest of Middle East and Africa: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
      • 10.4.10.2 Rest of Middle East and Africa: Pharmaceutical Intermediates Market, by Type, 2019-2028 (USD Million)
      • 10.4.10.3 Rest of Middle East and Africa: Pharmaceutical Intermediates Market, by Application, 2019-2028 (USD Million)
      • 10.4.10.4 Rest of Middle East and Africa: Pharmaceutical Intermediates Market, by Distribution Channel, 2019-2028 (USD Million)
  • 10.5 South and Central America: Pharmaceutical Intermediates Market Revenue and Forecast to 2028
    • 10.5.1 South and Central America: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
    • 10.5.2 South and Central America: Pharmaceutical Intermediates Market, by Type, 2019-2028 (USD Million)
    • 10.5.3 South and Central America: Pharmaceutical Intermediates Market, by Application, 2019-2028 (USD Million)
    • 10.5.4 South and Central America: Pharmaceutical Intermediates Market, by Distribution Channel, 2019-2028 (USD Million)
    • 10.5.5 South and Central America: Pharmaceutical Intermediates Market, by Country, 2020 & 2028 (%)
    • 10.5.6 Brazil: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
      • 10.5.6.1 Brazil: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
      • 10.5.6.2 Brazil: Pharmaceutical Intermediates Market, by Type, 2019-2028 (USD Million)
      • 10.5.6.3 Brazil: Pharmaceutical Intermediates Market, by Application, 2019-2028 (USD Million)
      • 10.5.6.4 Brazil: Pharmaceutical Intermediates Market, by Distribution Channel, 2019-2028 (USD Million)
    • 10.5.7 Argentina: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
      • 10.5.7.1 Argentina: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
      • 10.5.7.2 Argentina: Pharmaceutical Intermediates Market, by Type, 2019-2028 (USD Million)
      • 10.5.7.3 Argentina: Pharmaceutical Intermediates Market, by Application, 2019-2028 (USD Million)
      • 10.5.7.4 Argentina: Pharmaceutical Intermediates Market, by Distribution Channel, 2019-2028 (USD Million)
    • 10.5.8 Rest of South and Central America: Pharmaceutical Intermediates Market- Revenue and Forecasts to 2027 (USD Million)
      • 10.5.8.1 Rest of South and Central America: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
      • 10.5.8.2 Rest of South and Central America: Pharmaceutical Intermediates Market, by Type, 2019-2028 (USD Million)
      • 10.5.8.3 Rest of South and Central America: Pharmaceutical Intermediates Market, by Application, 2019-2028 (USD Million)
      • 10.5.8.4 Rest of South and Central America: Pharmaceutical Intermediates Market, by Distribution Channel, 2019-2028 (USD Million)

11. Impact of COVID-19 Pandemic on Global Pharmaceutical Intermediates Market

  • 11.1 North America: Impact Assessment of COVID-19 Pandemic
  • 11.2 Europe: Impact Assessment Of COVID-19 Pandemic
  • 11.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
  • 11.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
  • 11.5 South and Central America: Impact Assessment of COVID-19 Pandemic

12. Pharmaceutical Intermediates Market- Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies Done by the Companies in the Market, (%)
  • 12.3 Organic Developments
    • 12.3.1 Overview
  • 12.4 Inorganic Developments
    • 12.4.1 Overview

13. Company Profiles

  • 13.1 Pfizer Inc.
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Sanofi
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 BASF SE
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Lianhe Chemical Technology Co., Ltd.
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Dishman Carbogen Amcis Ltd
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Codexis
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Midas Pharma GmbH
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 chiracon GmbH
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 Dextra Laboratories Limited
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 Vertellus Holdings LLC
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments

14. Appendix

  • 14.1 About the Insight Partners
  • 14.2 Glossary of Terms

L

List Of Tables

  • Table 1. North America Pharmaceutical Intermediates Market, by Type - Revenue and Forecast to 2028 (USD Million)
  • Table 2. North America Pharmaceutical Intermediates Market, by Application - Revenue and Forecast to 2028 (USD Million)
  • Table 3. North America Pharmaceutical Intermediates Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
  • Table 4. US Pharmaceutical Intermediates Market, by Type - Revenue and Forecast to 2028 (USD Million)
  • Table 5. US Pharmaceutical Intermediates Market, by Application - Revenue and Forecast to 2028 (USD Million)
  • Table 6. US Pharmaceutical Intermediates Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
  • Table 7. Canada Pharmaceutical Intermediates Market, by Type - Revenue and Forecast to 2028 (USD Million)
  • Table 8. Canada Pharmaceutical Intermediates Market, by Application - Revenue and Forecast to 2028 (USD Million)
  • Table 9. Canada Pharmaceutical Intermediates Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
  • Table 10. Mexico Pharmaceutical Intermediates Market, by Type - Revenue and Forecast to 2028 (USD Million)
  • Table 11. Mexico Pharmaceutical Intermediates Market, by Application - Revenue and Forecast to 2028 (USD Million)
  • Table 12. Mexico Pharmaceutical Intermediates Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
  • Table 13. Europe Pharmaceutical Intermediates Market, by Type - Revenue and Forecast to 2028 (USD Million)
  • Table 14. Europe Pharmaceutical Intermediates Market, by Application - Revenue and Forecast to 2028 (USD Million)
  • Table 15. Europe Pharmaceutical Intermediates Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
  • Table 16. Germany Pharmaceutical Intermediates Market, by Type - Revenue and Forecast to 2028 (USD Million)
  • Table 17. Germany Pharmaceutical Intermediates Market, by Application - Revenue and Forecast to 2028 (USD Million)
  • Table 18. Germany Pharmaceutical Intermediates Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
  • Table 19. UK Pharmaceutical Intermediates Market, by Type - Revenue and Forecast to 2028 (USD Million)
  • Table 20. UK Pharmaceutical Intermediates Market, by Application - Revenue and Forecast to 2028 (USD Million)
  • Table 21. UK Pharmaceutical Intermediates Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
  • Table 22. France Pharmaceutical Intermediates Market, by Type - Revenue and Forecast to 2028 (USD Million)
  • Table 23. France Pharmaceutical Intermediates Market, by Application - Revenue and Forecast to 2028 (USD Million)
  • Table 24. France Pharmaceutical Intermediates Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
  • Table 25. Spain Pharmaceutical Intermediates Market, by Type - Revenue and Forecast to 2028 (USD Million)
  • Table 26. Spain Pharmaceutical Intermediates Market, by Application - Revenue and Forecast to 2028 (USD Million)
  • Table 27. Spain Pharmaceutical Intermediates Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
  • Table 28. Italy Pharmaceutical Intermediates Market, by Type - Revenue and Forecast to 2028 (USD Million)
  • Table 29. Italy Pharmaceutical Intermediates Market, by Application - Revenue and Forecast to 2028 (USD Million)
  • Table 30. Italy Pharmaceutical Intermediates Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
  • Table 31. Rest of Europe Pharmaceutical Intermediates Market, by Type - Revenue and Forecast to 2028 (USD Million)
  • Table 32. Rest of Europe Pharmaceutical Intermediates Market, by Application - Revenue and Forecast to 2028 (USD Million)
  • Table 33. Rest of Europe Pharmaceutical Intermediates Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
  • Table 34. Asia Pacific Pharmaceutical Intermediates Market, by Type - Revenue and Forecast to 2028 (USD Million)
  • Table 35. Asia Pacific Pharmaceutical Intermediates Market, by Application - Revenue and Forecast to 2028 (USD Million)
  • Table 36. Asia Pacific Pharmaceutical Intermediates Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
  • Table 37. China Pharmaceutical Intermediates Market, by Type - Revenue and Forecast to 2028 (USD Million)
  • Table 38. China Pharmaceutical Intermediates Market, by Application - Revenue and Forecast to 2028 (USD Million)
  • Table 39. China Pharmaceutical Intermediates Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
  • Table 40. Japan Pharmaceutical Intermediates Market, by Type - Revenue and Forecast to 2028 (USD Million)
  • Table 41. Japan Pharmaceutical Intermediates Market, by Application - Revenue and Forecast to 2028 (USD Million)
  • Table 42. Japan Pharmaceutical Intermediates Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
  • Table 43. India Pharmaceutical Intermediates Market, by Type - Revenue and Forecast to 2028 (USD Million)
  • Table 44. India Pharmaceutical Intermediates Market, by Application - Revenue and Forecast to 2028 (USD Million)
  • Table 45. India Pharmaceutical Intermediates Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
  • Table 46. Australia Pharmaceutical Intermediates Market, by Type - Revenue and Forecast to 2028 (USD Million)
  • Table 47. Australia Pharmaceutical Intermediates Market, by Application - Revenue and Forecast to 2028 (USD Million)
  • Table 48. Australia Pharmaceutical Intermediates Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
  • Table 49. South Korea Pharmaceutical Intermediates Market, by Type - Revenue and Forecast to 2028 (USD Million)
  • Table 50. South Korea Pharmaceutical Intermediates Market, by Application - Revenue and Forecast to 2028 (USD Million)
  • Table 51. South Korea Pharmaceutical Intermediates Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
  • Table 52. Rest of Asia Pacific Pharmaceutical Intermediates Market, by Type - Revenue and Forecast to 2028 (USD Million)
  • Table 53. Rest of Asia Pacific Pharmaceutical Intermediates Market, by Application - Revenue and Forecast to 2028 (USD Million)
  • Table 54. Rest of Asia Pacific Pharmaceutical Intermediates Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
  • Table 55. Middle East and Africa Pharmaceutical Intermediates Market, by Type - Revenue and Forecast to 2028 (USD Million)
  • Table 56. Middle East and Africa Pharmaceutical Intermediates Market, by Application - Revenue and Forecast to 2028 (USD Million)
  • Table 57. Middle East and Africa Pharmaceutical Intermediates Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
  • Table 58. Saudi Arabia Pharmaceutical Intermediates Market, by Type - Revenue and Forecast to 2028 (USD Million)
  • Table 59. Saudi Arabia Pharmaceutical Intermediates Market, by Application - Revenue and Forecast to 2028 (USD Million)
  • Table 60. Saudi Arabia Pharmaceutical Intermediates Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
  • Table 61. UAE Pharmaceutical Intermediates Market, by Type - Revenue and Forecast to 2028 (USD Million)
  • Table 62. UAE Pharmaceutical Intermediates Market, by Application - Revenue and Forecast to 2028 (USD Million)
  • Table 63. UAE Pharmaceutical Intermediates Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
  • Table 64. South Africa Pharmaceutical Intermediates Market, by Type - Revenue and Forecast to 2028 (USD Million)
  • Table 65. South Africa Pharmaceutical Intermediates Market, by Application - Revenue and Forecast to 2028 (USD Million)
  • Table 66. South Africa Pharmaceutical Intermediates Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
  • Table 67. Rest of Middle East and Africa Pharmaceutical Intermediates Market, by Type - Revenue and Forecast to 2028 (USD Million)
  • Table 68. Rest of Middle East and Africa Pharmaceutical Intermediates Market, by Application - Revenue and Forecast to 2028 (USD Million)
  • Table 69. Rest of Middle East and Africa Pharmaceutical Intermediates Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
  • Table 70. South and Central America Pharmaceutical Intermediates Market, by Type - Revenue and Forecast to 2028 (USD Million)
  • Table 71. South and Central America Pharmaceutical Intermediates Market, by Application - Revenue and Forecast to 2028 (USD Million)
  • Table 72. South and Central America Pharmaceutical Intermediates Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
  • Table 73. Brazil Pharmaceutical Intermediates Market, by Type - Revenue and Forecast to 2028 (USD Million)
  • Table 74. Brazil Pharmaceutical Intermediates Market, by Application - Revenue and Forecast to 2028 (USD Million)
  • Table 75. Brazil Pharmaceutical Intermediates Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
  • Table 76. Argentina Pharmaceutical Intermediates Market, by Type - Revenue and Forecast to 2028 (USD Million)
  • Table 77. Argentina Pharmaceutical Intermediates Market, by Application - Revenue and Forecast to 2028 (USD Million)
  • Table 78. Argentina Pharmaceutical Intermediates Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
  • Table 79. Rest of South and Central America Pharmaceutical Intermediates Market, by Type - Revenue and Forecast to 2028 (USD Million)
  • Table 80. Rest of South and Central America Pharmaceutical Intermediates Market, by Application - Revenue and Forecast to 2028 (USD Million)
  • Table 81. Rest of South and Central America Pharmaceutical Intermediates Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
  • Table 82. Organic Developments Done By Companies
  • Table 83. Inorganic Developments Done By Companies
  • Table 84. Glossary of Terms, Pharmaceutical Intermediates Market

List Of Figures

  • Figure 1. Pharmaceutical Intermediates Market Segmentation
  • Figure 2. Pharmaceutical Intermediates Segmentation, By Region
  • Figure 3. Global Pharmaceutical Intermediates Market Overview
  • Figure 4. GMP Held Largest Share of Type Segment in Pharmaceutical Intermediates Market
  • Figure 5. Asia Pacific to Show Remarkable Growth During Forecast Period
  • Figure 6. Pharmaceutical Intermediates Market, by Geography (US$ Million)
  • Figure 7. Global Pharmaceutical Intermediates Market- Leading Country Markets (US$ Million)
  • Figure 8. Global Pharmaceutical Intermediates Market, Industry Landscape
  • Figure 9. North America: PEST Analysis
  • Figure 10. Europe: PEST Analysis
  • Figure 11. APAC: PEST Analysis
  • Figure 12. MEA: PEST Analysis
  • Figure 13. SCAM: PEST Analysis
  • Figure 14. Expert Opinion
  • Figure 15. Pharmaceutical Intermediates Market Impact Analysis of Driver and Restraints
  • Figure 16. Global Pharmaceutical Intermediates Market- Revenue Forecast and Analysis - 2020- 2028
  • Figure 17. Global Pharmaceutical Intermediates Market- By Geography Forecast and Analysis - 2020- 2028
  • Figure 18. Market Positioning of Key Players in Global Pharmaceutical Intermediates Market
  • Figure 19. Pharmaceutical Intermediates Market Revenue Share, by Type (2020 and 2028)
  • Figure 20. GMP: Pharmaceutical Intermediates Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 21. Non GMP Pharmaceutical Intermediates Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 22. Pharmaceutical Intermediates Market Revenue Share, by Application (2020 and 2028)
  • Figure 23. Antibiotics: Pharmaceutical Intermediates Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 24. Antipyretic Analgesics: Pharmaceutical Intermediates Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 25. Vitamins: Pharmaceutical Intermediates Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 26. Other: Pharmaceutical Intermediates Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 27. Pharmaceutical Intermediates Market, by Distribution Channel, 2020 and 2028 (%)
  • Figure 28. Distributor: Pharmaceutical Intermediates Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 29. Direct Sales: Pharmaceutical Intermediates Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 30. North America: Pharmaceutical Intermediates Market, by Key Country - Revenue (2020) (USD Million)
  • Figure 31. North America Pharmaceutical Intermediates Market Revenue and Forecast to 2028 (USD Million)
  • Figure 32. North America: Pharmaceutical Intermediates Market, by Country, 2020 & 2028 (%)
  • Figure 33. US: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 34. Canada: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 35. Mexico: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 36. Europe: Pharmaceutical Intermediates Market, by Key Country - Revenue (2020) (USD Million)
  • Figure 37. Europe Pharmaceutical Intermediates Market Revenue and Forecast to 2028 (USD Million)
  • Figure 38. Europe: Pharmaceutical Intermediates Market, by Country, 2020 & 2028 (%)
  • Figure 39. Germany: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 40. UK: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 41. France: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 42. Spain: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 43. Italy: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 44. Rest of Europe: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 45. Asia Pacific: Pharmaceutical Intermediates Market, by Key Country - Revenue (2020) (USD Million)
  • Figure 46. Asia Pacific Pharmaceutical Intermediates Market Revenue and Forecast to 2028 (USD Million)
  • Figure 47. Asia Pacific: Pharmaceutical Intermediates Market, by Country, 2020 & 2028 (%)
  • Figure 48. China: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 49. Japan: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 50. India: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 51. Australia: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 52. South Korea: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 53. Rest of Asia Pacific: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 54. Middle East and Africa: Pharmaceutical Intermediates Market, by Key Country - Revenue (2020) (USD Million)
  • Figure 55. Middle East and Africa Pharmaceutical Intermediates Market Revenue and Forecast to 2028 (USD Million)
  • Figure 56. Middle East and Africa: Pharmaceutical Intermediates Market, by Country, 2020 & 2028 (%)
  • Figure 57. Saudi Arabia: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 58. UAE: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 59. South Africa: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 60. Rest of Middle East and Africa: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 61. South and Central America: Pharmaceutical Intermediates Market, by Key Country - Revenue (2020) (USD Million)
  • Figure 62. South and Central America Pharmaceutical Intermediates Market Revenue and Forecast to 2028 (USD Million)
  • Figure 63. South and Central America: Pharmaceutical Intermediates Market, by Country, 2020 & 2028 (%)
  • Figure 64. Brazil: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 65. Argentina: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 66. Rest of South and Central America: Pharmaceutical Intermediates Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 67. Impact of COVID-19 Pandemic in North American Country Markets
  • Figure 68. Impact of COVID-19 Pandemic in European Country Markets
  • Figure 69. Impact of COVID-19 Pandemic on Pharmaceutical Intermediates Market in Asia Pacific Countries
  • Figure 70. Impact of COVID-19 Pandemic in Middle East and Africa Market
  • Figure 71. Impact of COVID-19 Pandemic in South and Central America Market
  • Figure 72. Growth Strategies Done by the Companies in the Market, (%)